James L. Gulley, MD, PhD, FACP, National Cancer Institute, explains First In-Class Agent Targeting PD-L1 & TGF-? | There Are Other Agents in Pre-Clinical Testing at Annual Meeting 2018
James L. Gulley, MD, PhD, FACP, National Cancer Institute, explains First In-Class Agent Targeting PD-L1 & TGF-? | There Are Other Agents in Pre-Clinical Testing at Annual Meeting 2018